{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:52:29Z","timestamp":1787838749495,"version":"build-2784847793"},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Clinical Apheresis"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Adverse donor events (ADEs) are usually mild and short\u2010term with no sequelae, but may cause disinclination toward future donations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To determine the impact of delayed ADEs (D\u2010ADEs) in addition to immediate ADEs (I\u2010ADEs) on the intention of future donations (IFDs) and to analyze the various associated factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>ADEs were categorized following the ISBT working group on donor vigilance. Telephonic interviews of the donors were conducted 2\u2009weeks after the whole blood (WB) and plateletpheresis donation to inquire about D\u2010ADEs and IFDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 3514 WB and 531 plateletpheresis donors were included in the study. WB donors had an overall higher IFD as compared to plateletpheresis donors (89.53% vs 57.06%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001). A higher IFD was observed in male WB donors as compared to female WB donors (89.95% vs 75%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001). Repeat WB donors had a higher IFD as compared with first\u2010time donors (93.66% vs 81.37%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001). A total of 13.7% WB donors and 19.2% plateletpheresis donors reported D\u2010ADEs. WB donors who experienced D\u2010ADEs had a significantly lower IFD (78.38% vs 91.63%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001) as compared with donors without any ADEs; a similar trend was observed in donors who experienced I\u2010ADEs (69.90% vs 91.63%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001). In WB donors, systemic D\u2010ADEs such as fatigue had a more negative impact on IFDs as compared with localized D\u2010ADEs such as bruises (63.93% vs 86.83%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u2009.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Both D\u2010ADEs and I\u2010ADEs negatively impact donors' intention to donate again. Systemic D\u2010ADEs had a more negative impact on IFDs as compared with localized D\u2010ADEs.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jca.21902","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T12:34:50Z","timestamp":1620131690000},"page":"621-627","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of delayed and immediate adverse events on the intention of future donations in whole blood and plateletpheresis donors"],"prefix":"10.1002","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-4858","authenticated-orcid":false,"given":"Abhaykumar Malind","family":"Gupta","sequence":"first","affiliation":[{"name":"Department of Transfusion Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4872-7845","authenticated-orcid":false,"given":"Meenu","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine Institute of Liver and Biliary Sciences  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00368.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2016.10.009"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01519.x"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2006.00905.x"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2012.05.002"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2003.08.014"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2005.02.005"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/0145445510362576"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03551.x"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01409.x"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02288.x"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2011.03216.x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2007.01600.x"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1998.38498257374.x"},{"key":"e_1_2_9_16_1","unstructured":"Standard for Surveillance of Complications Related to Blood Donation ISBT;2015. Available fromhttp:\/\/www.isbtweb.org\/fileadmin\/user_upload\/files-2015\/haemovigilance\/definitions\/Standard%202008%20remark%20surveillance%20complications%20related%20to%20blood%20donation%20haemovigilance.pdf Accessed March 22 2021."},{"key":"e_1_2_9_17_1","article-title":"Delayed adverse reactions in whole blood donors: the importance of active surveillance in identifying the missing gaps in the donor safety","author":"Gupta AM","journal-title":"Indian J Med Res"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21753"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2011.04.005"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12796"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2010.02618.x"}],"container-title":["Journal of Clinical Apheresis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.21902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jca.21902","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jca.21902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T18:38:15Z","timestamp":1693334295000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jca.21902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1002\/jca.21902"],"URL":"https:\/\/doi.org\/10.1002\/jca.21902","archive":["Portico"],"relation":{},"ISSN":["0733-2459","1098-1101"],"issn-type":[{"value":"0733-2459","type":"print"},{"value":"1098-1101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"2021-03-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}